The markets jumped for joy amid a new possible COVID-19 vaccine - Tuesday Review, December 1

The markets jumped for joy amid a new possible COVID-19 vaccine - Tuesday Review, December 1

Stocks traded higher on vaccine data

The US

The benchmarks rejoiced as Pfizer and BioNTech filed for European approval for their COVID-19 vaccine. Moreover, rumor has it that discussions about a new stimulus package will be resumed. USA30 gained 0.91%, while USA500 closed 1.34% higher. TECH100 rose 1.39%.

Crude Oil closed 0.6% higher at $45.69 a barrel.

Gold rose 2.1% to $1,818.90 per ounce.

Asia and Australia

HongKong45 was up 0.37% even though the rising number of #COVID-19 infections is forcing the administration to impose tighter restrictions.

Japan255 gained 1.39%.

Down under, Australia200 surged 1.34% as investors believe that the Reserve Bank of Australia will keep its policy unchanged.

Europe

The benchmarks closed higher, driven by the positive COVID-19 #vaccine data. Also, the positive economic readings added some steam. Germany30 and UK100 each added 1%. France40 went up 1.7%.

Brent Oil rose 0.8% to $48.26 per barrel.

EUR/USD traded at 1.1976 after it jumped 0.4%.

Sources: reuters.com, investing.com

The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.

Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.